Children born during the first year of the pandemic, including those exposed to COVID in utero, were no more likely to screen positive for autism than unexposed or pre-pandemic children, found researchers from Columbia University Vagelos College of Physicians and Surgeons.
With new data, AstraZeneca makes the case for its BTK inhibitor in a first-line setting
Combined with chemotherapy and immunotherapy, AstraZeneca’s Calquence reduced the risk of disease progression or death by 27% compared to placebo and chemoimmunotherapy in first-line mantle